APA (7th ed.) Citation

J, W., J, D., Y, L., Y, X., J, H., & X, Z. (2024). Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China. Vaccines, 12(12), . https://doi.org/10.3390/vaccines12121376

Chicago Style (17th ed.) Citation

J, Wang, Du J, Liu Y, Xu Y, Han J, and Zhang X. "Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China." Vaccines 12, no. 12 (2024). https://doi.org/10.3390/vaccines12121376.

MLA (9th ed.) Citation

J, Wang, et al. "Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China." Vaccines, vol. 12, no. 12, 2024, https://doi.org/10.3390/vaccines12121376.